Researcher.Life Logo

Drug Development Research : Impact Factor & More

eISSN: 1098-2299pISSN: 0272-4391

Key Metrics

CiteScore
5.2
H-Index
65
Impact Factor
< 5
SJR
Q2Drug Discovery
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Development Research

Drug Development Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Development Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development Research

Kv1.3 Channel Blockade by Dalfampridine Attenuates NLRP3 Inflammasome-Driven Demyelination via the NEK7/Ripk1/FADD Pathway, Matching the Efficacy of Broad P2X7 Antagonism by Suramin in EAE.
  • 1 May 2026
  • Drug development research
Antitumor Activity of Sodium Selenite, Palbociclib, and Disulfiram Against Osteosarcoma and Rhabdomyosarcoma Cell Lines.
  • 1 May 2026
  • Drug development research
Dual-Function Lipid-Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization.
  • 1 May 2026
  • Drug development research
Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship.
  • 1 May 2026
  • Drug development research
Heterocyclic Scaffold Modification of Chalcones: Piperidinyl and Morpholinyl Triazene Derivatives as Potent Blood Stage Antimalarials With SAR and Docking Insights.
  • 1 May 2026
  • Drug development research
Nanoplatform-Based Delivery Systems for PROTACs.
  • 1 May 2026
  • Drug development research
Kv1.3 Channel Blockade by Dalfampridine Attenuates NLRP3 Inflammasome-Driven Demyelination via the NEK7/Ripk1/FADD Pathway, Matching the Efficacy of Broad P2X7 Antagonism by Suramin in EAE.
  • 1 May 2026
  • Drug development research
Antitumor Activity of Sodium Selenite, Palbociclib, and Disulfiram Against Osteosarcoma and Rhabdomyosarcoma Cell Lines.
  • 1 May 2026
  • Drug development research
Dual-Function Lipid-Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization.
  • 1 May 2026
  • Drug development research
Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship.
  • 1 May 2026
  • Drug development research
Heterocyclic Scaffold Modification of Chalcones: Piperidinyl and Morpholinyl Triazene Derivatives as Potent Blood Stage Antimalarials With SAR and Docking Insights.
  • 1 May 2026
  • Drug development research
Nanoplatform-Based Delivery Systems for PROTACs.
  • 1 May 2026
  • Drug development research

FAQs on Drug Development Research